Endocrinology
Myth of the Month
Can this patient get IV contrast?
Patients with seafood allergy have a higher rate of reactions to iodinated contrast, but not at a higher rate than patients with other food...
Latest News
In gestational diabetes, early postpartum glucose testing is a winner
GRAPEVINE, TEX. – Inpatient postpartum testing captured 99 of 100 patients without sacrificing accuracy.
From the Journals
Endocrine Society advises on use of romosozumab for osteoporosis
The update to the 2019 guideline specifies which postmenopausal women should, and should not, receive the drug.
From the Journals
Thyroid dysfunction is common in patients with diabetes
An Australian study finds a high rate of baseline thyroid dysfunction in all categories of diabetes.
News from the FDA/CDC
FDA approves weekly contraceptive patch Twirla
The levonorgestrel and ethinyl estradiol contraceptive is contraindicated in obese women.
Conference Coverage
Noninjectable modes of insulin delivery coming of age
From the Journals
Zoledronate promotes postdenosumab bone retention
Osteoporosis patients given a single infusion of zoledronate after denosumab retained more than half of bone mineral density gains.
Photo Rounds
Right hip and pelvic pain
Follow-up imaging confirmed a clinical suspicion.
Case Reports
33-year-old man • flaccid paralysis in limbs • 30-lb weight loss • thyromegaly without nodules • Dx?
► Flaccid paralysis in arms and legs
► 30-lb weight loss in previous month
► Thyromegaly without nodules
News
Teprotumumab gets FDA go-ahead for thyroid eye disease
It is the first drug to be approved for treatment of the debilitating, autoimmune condition.
Conference Coverage
Testosterone gel increases LV mass in older men
PHILADELPHIA – The clinical implications of this hormonal therapy–induced jump in left ventricular mass remain unclear.